How to diagnose and treat patients with inflammatory bowel disease

Inflammatory bowel diseases (IBD) are idiopathic, chronic intestinal inflammatory diseases. IBD pathogenesis is related to altered immune response and its complex interaction with gut microbiota, genetic and environmental factors. Most common types of IBD are ulcerative colitis (UC) and Crohns disea...

Full description

Bibliographic Details
Main Author: Sokić-Milutinović Aleksandra
Format: Article
Language:srp
Published: Pharmaceutical Association of Serbia, Belgrade, Serbia 2017-01-01
Series:Arhiv za farmaciju
Subjects:
Online Access:https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2017/0004-19631702091S.pdf
_version_ 1818734045694001152
author Sokić-Milutinović Aleksandra
author_facet Sokić-Milutinović Aleksandra
author_sort Sokić-Milutinović Aleksandra
collection DOAJ
description Inflammatory bowel diseases (IBD) are idiopathic, chronic intestinal inflammatory diseases. IBD pathogenesis is related to altered immune response and its complex interaction with gut microbiota, genetic and environmental factors. Most common types of IBD are ulcerative colitis (UC) and Crohns disease (CD), while a subset of patients suffer from undetermined IBD. Ulcerative colitis is chronic inflammatory disease limited to colonic musoa. As opposed to UC, CD is chronic granulomatous disease that can affect any segment of the gastrointestinal tract and all layers of bowel wall. Extraintestinal manifestations of IBD include musculoskeletal, dermatological, ocular and hepatobiliary manifestations. IBD diagnosis is based on clinical presentation, laboratory findings, endoscopic procedures with patohistological examination of tissue biopsies. In some patients additional radiographic diagnostic tools are needed. Therapy in IBD patients is based on the use of mesalamines and sulphasalazyne, corticosteroids, immunomodulators, biologic therapy and surgery. Mesalamines are used as induction therapy in UC patients, while corticosteroids and biologic therapy can be used as induction therapy in both UC and CD patients. Maintenance therapy in UC consists of mesalamines, thiopurines and biologics, while in CD thiopurines, methotrexate and biologics can be used. In pediatric patients nutritional therapy can be beneficial.
first_indexed 2024-12-17T23:59:07Z
format Article
id doaj.art-bac2c99ca019442ca8e53bbb3eee353c
institution Directory Open Access Journal
issn 0004-1963
2217-8767
language srp
last_indexed 2024-12-17T23:59:07Z
publishDate 2017-01-01
publisher Pharmaceutical Association of Serbia, Belgrade, Serbia
record_format Article
series Arhiv za farmaciju
spelling doaj.art-bac2c99ca019442ca8e53bbb3eee353c2022-12-21T21:28:00ZsrpPharmaceutical Association of Serbia, Belgrade, SerbiaArhiv za farmaciju0004-19632217-87672017-01-016729111110.5937/arhfarm1702091S0004-19631702091SHow to diagnose and treat patients with inflammatory bowel diseaseSokić-Milutinović Aleksandra0Klinika za gastroenterologiju i hepatologiju, Klinički centar Srbije, Beograd, SerbiaInflammatory bowel diseases (IBD) are idiopathic, chronic intestinal inflammatory diseases. IBD pathogenesis is related to altered immune response and its complex interaction with gut microbiota, genetic and environmental factors. Most common types of IBD are ulcerative colitis (UC) and Crohns disease (CD), while a subset of patients suffer from undetermined IBD. Ulcerative colitis is chronic inflammatory disease limited to colonic musoa. As opposed to UC, CD is chronic granulomatous disease that can affect any segment of the gastrointestinal tract and all layers of bowel wall. Extraintestinal manifestations of IBD include musculoskeletal, dermatological, ocular and hepatobiliary manifestations. IBD diagnosis is based on clinical presentation, laboratory findings, endoscopic procedures with patohistological examination of tissue biopsies. In some patients additional radiographic diagnostic tools are needed. Therapy in IBD patients is based on the use of mesalamines and sulphasalazyne, corticosteroids, immunomodulators, biologic therapy and surgery. Mesalamines are used as induction therapy in UC patients, while corticosteroids and biologic therapy can be used as induction therapy in both UC and CD patients. Maintenance therapy in UC consists of mesalamines, thiopurines and biologics, while in CD thiopurines, methotrexate and biologics can be used. In pediatric patients nutritional therapy can be beneficial.https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2017/0004-19631702091S.pdfinflammatory bowel diseaseulcerative colitiscrohn diseasediagnosistherapy
spellingShingle Sokić-Milutinović Aleksandra
How to diagnose and treat patients with inflammatory bowel disease
Arhiv za farmaciju
inflammatory bowel disease
ulcerative colitis
crohn disease
diagnosis
therapy
title How to diagnose and treat patients with inflammatory bowel disease
title_full How to diagnose and treat patients with inflammatory bowel disease
title_fullStr How to diagnose and treat patients with inflammatory bowel disease
title_full_unstemmed How to diagnose and treat patients with inflammatory bowel disease
title_short How to diagnose and treat patients with inflammatory bowel disease
title_sort how to diagnose and treat patients with inflammatory bowel disease
topic inflammatory bowel disease
ulcerative colitis
crohn disease
diagnosis
therapy
url https://scindeks-clanci.ceon.rs/data/pdf/0004-1963/2017/0004-19631702091S.pdf
work_keys_str_mv AT sokicmilutinovicaleksandra howtodiagnoseandtreatpatientswithinflammatoryboweldisease